You are correct about Defencath has it has a limited target population. I am there as they are about to sign up a couple more dialysis providers and technically the stock looks strong and I plan to be out in the near future - upon positive news.
I have been slowly over the last number of years funneling proceeds from bio/spec sales into mid/large cap div payers. 2025 will require me to start RMDs in my tax sheltered account. My taxable brokerage account is already completely in dividend stocks save for AMRN. With interest rates dropping in the coming year my savings accounts will be bringing me much less interest income at a time that I moved to a more expensive area to live - what was I thinking?
Market Data 
Markets 
AI
